反应详情

N-[(6R,7S)-6-Ethyl-2-fluoro-8-oxo-9-(2,2,2-trifluoro-ethyl)-6,7,8,9-tetrahydro-5-oxa-9-aza-benzocyclohepten-7-yl]-(R or S)-2-hydroxy-2-methyl-N′-(2,2,2-trifluoro-ethyl)-malonamide, entity A, was obtained according to the procedures described for example 2b using (S or R)-2-hydroxy-2-methyl-N-(2,2,2-trifluoro-ethyl)-malonamic acid, entity B (example 72), and (6R,7S)-7-amino-6-ethyl-2-fluoro-9-(2,2,2-trifluoro-ethyl)-6,7-dihydro-9H-5-oxa-9-aza-benzocyclohepten-8-one, MS m/e (%): 504.0 (M+H+, 100). N-[(6R,7S)-6-Ethyl-2-fluoro-8-oxo-9-(2,2,2-trifluoro-ethyl)-6,7,8,9-tetrahydro-5-oxa-9-aza-benzocyclohepten-7-yl]-(R or S)-2-hydroxy-2-methyl-N′-(2,2,2-trifluoro-ethyl)-malonamide, entitiy B, was obtained according to the procedures described for example 2b using (S or R)-2-hydroxy-2-methyl-N-(2,2,2-trifluoro-ethyl)-malonamic acid, entity A (example 72), and (6R,7S)-7-amino-6-ethyl-2-fluoro-9-(2,2,2-trifluoro-ethyl)-6,7-dihydro-9H-5-oxa-9-aza-benzocyclohepten-8-one, MS m/e (%): 504.0 (M+H+, 100).